Valuation: Beijing Beilu Pharmaceutical Co., Ltd.

Market Cap 4.55B 672M 590M 549M 505M 947M 64.2B 963M 6.52B 2.55B 31.84B 2.52B 2.47B 110B P/E 2024
207x
P/E 2025 44.1x
Enterprise Value 4.38B 647M 568M 529M 486M 912M 61.82B 927M 6.27B 2.46B 30.66B 2.43B 2.38B 106B EV / Sales 2024
3.29x
EV / Sales 2025 3.57x
Free-Float
56.4%
Yield 2024
0.81%
Yield 2025 -
1 day+0.13%
1 week+4.25%
Current month+2.35%
1 month+8.58%
3 months-14.30%
6 months-13.55%
Current year-1.13%
1 week 7.31
Extreme 7.31
8.1
1 month 7.15
Extreme 7.15
8.78
Current year 7.08
Extreme 7.08
11.38
1 year 7.08
Extreme 7.08
11.98
3 years 3.58
Extreme 3.58
11.98
5 years 3.58
Extreme 3.58
11.98
10 years 3.58
Extreme 3.58
14.86
Manager TitleAgeSince
Chief Executive Officer 42 11/12/2017
Director of Finance/CFO 34 01/08/2019
Chief Operating Officer 45 25/08/2022
Director TitleAgeSince
Chairman 42 01/08/2019
Chairman 48 21/03/2019
Director/Board Member 46 21/03/2019
Date Insider Type Main position Quantity % Market Cap.
14/9/21 Sell

Executive/Senior Manager

10,000 0.0025%
10/9/21 Sell

Executive/Senior Manager

77,000 0.0189%
9/6/21 Sell

Executive/Senior Manager

60,000 0.0150%
Change 5-day change 1-year change 3-year change Capi.($)
+0.13%+4.25%-11.10%+16.82% 675M
+0.07%+5.09%+60.20%+168.89% 1,089B
+0.43%+4.58%+59.03%+59.58% 643B
+1.20%+4.83%+38.87%+77.52% 465B
-1.03%+9.54%+40.31%+34.55% 359B
-0.58%+3.53%+36.99%+42.48% 303B
+1.56%+3.45%+17.76%+17.47% 267B
+0.45%+5.60%-2.74%-38.22% 226B
+0.39%+8.00%+30.24%+68.84% 212B
-0.83%+2.77%+17.27%+75.93% 167B
Average +0.18%+4.95%+28.68%+52.39% 373.18B
Weighted average by Cap. +0.21%+5.14%+43.05%+82.21%

Financials

2024 2025
Net sales 984M 145M 128M 119M 109M 205M 13.88B 208M 1.41B 551M 6.88B 546M 534M 23.79B 1.21B 178M 156M 146M 134M 251M 17.01B 255M 1.73B 676M 8.44B 668M 654M 29.15B
Net income 13.65M 2.02M 1.77M 1.65M 1.52M 2.84M 193M 2.89M 19.55M 7.65M 95.56M 7.57M 7.41M 330M 92.73M 13.7M 12.02M 11.2M 10.3M 19.3M 1.31B 19.64M 133M 51.99M 649M 51.43M 50.32M 2.24B
Net Debt 189M 27.93M 24.52M 22.83M 21M 39.36M 2.67B 40.04M 271M 106M 1.32B 105M 103M 4.57B -169M -24.94M -21.89M -20.38M -18.75M -35.14M -2.38B -35.74M -242M -94.64M -1.18B -93.63M -91.61M -4.08B
Logo Beijing Beilu Pharmaceutical Co., Ltd.
Beijing Beilu Pharmaceutical Co Ltd is a China-based company principally engaged in the research, development, production and sales of chemical drugs (including active pharmaceutical ingredients) and traditional Chinese medicine. The chemical drug business mainly focuses on the research, development, production and sales of contrast agents, hypoglycemic drugs and other products. The traditional Chinese medicine segment mainly focuses on the production and sales of central nervous system, heat-clearing and detoxifying, and tonic products. The Company's main products include gadopentetate dimeglumine injection, iohexol injection, repaglinide tablets, iohexol active pharmaceutical ingredient, Jiuwei Zhenxin Granules, Jinlianhua Granules, Qingwei Huanglian Pills and others. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
1,188
Date Price Change Volume
28/07/26 CNY 7.850 +0.13% 20,343,296
27/07/26 CNY 7.840 +6.09% 23,296,228
24/07/26 CNY 7.390 -4.03% 14,678,436
23/07/26 CNY 7.700 +1.85% 16,190,736
22/07/26 CNY 7.560 +0.40% 19,804,200

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300016 Stock